Tesseract Structural Innovations Partners with Cymat in APMA Electric Vehicle Project Arrow

Mississauga, Ontario – Cymat Technologies Ltd. (TSXV: CYM) (the "Company" or "Cymat") is pleased to announce that, in collaboration with design partner Tesseract Structural Innovations Inc. (“Tesseract”), Cymat has...

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

Leading expert in alopecia, Dr. Brett King brings deep academic insight, broad preclinical and clinical expertise and drug development experience to help BiologicsMD advance its innovative hair and bone therapies New...

VIC Fellows Spotlight: Danielle France, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

Dr. Davies-Cutting Brings Industry Leading Technical Expertise to Nob Hill Therapeutics

Albuquerque. NM, Nob Hill Therapeutics announced today the appointment of Craig Davies-Cutting, PhD, as Vice President of Research and Development. Dr. Davies-Cutting will contribute his extensive respiratory product...

Individual Investor Access to VC Stage Investments

In my last article, I discussed why individual investors should include privately held, innovation-driven companies in a diversified and balanced investment strategy [Seven Reasons Venture Capital-Stage Companies Should...

Filtravate Awarded National Science Foundation SBIR Phase I Grant

LAS CRUCES, NM - Filtravate, an ultrafiltration membrane company, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF) for...

VIC Foundry Awarded an NIH Grant for Development of Instrument for Ultrafast Detection of Protein Biomarkers

Instrument Will Enable Near Real-Time Detection of Biomarkers and Drug Targets Fayetteville, AR - VIC Foundry, in collaboration with the University of Buffalo, has been awarded a $259,000 grant from the National...

MedTech Development Built Upon Outstanding Medical Advice

Innovation in medicine shouldn’t be taken for granted. Medical revolutions like vaccines, antibiotics, recombinant human insulin, pacemakers, cardiopulmonary resuscitation, magnetic resonance imaging, and immunotherapy...

Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO

Albuquerque, NM - Nob Hill Therapeutics (NHT), a VIC Technology Venture Development portfolio company, announced today that it has received an HHS phase II grant (up to $1.73M) to develop an inhaled therapy to treat...

VIC Tech Continues to Grow Its Medical Advisory Board

VIC Tech is pleased to announce the addition of four new members to its Medical Advisory Board to help guide VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Our Life Science and Healthcare Future
White Paper
Portfolio Diversification in Times of Market Volatility
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Karim ReFaey, MD
From The Corner Office
From the Corner Office: Zebra Analytix